baber/WOPTO huggingface dataset:
Patent NZ-514526-A (NZ)
Title: Casting strip
Inventor: ZIEGELAAR JOHN ALBERT
IPC: B21C47/26
Filed: 2000-04-07
Abstract: Twin  roll caster (11) produces cast steel strip  (12) that  passes in a transit path (10) through pinch roll stand (14)  and  optional hot rolling mill (15) and  runout  table (17)  to  a  coiling  station  (19)  which  has  a  pair  of switchable coilers (85, 86).  A strip shear (81) located  in advance  of  the coiling station is operable to sever  strip (12)  into discrete lengths which can be diverted by setting deflectors  (82,  84) to allow the severed lengths  to  pass across  a runout table (83) to a scrap bin (87).  The  strip may be thus severed and diverted to scrap on development  of strip   defects  or  malfunctioning  of  equipment   without stopping continuous casting and the strip redirected to  the coiling station when the problem is rectified.
Patent NZ-514933-A (NZ)
Title: Inflatable device and method for treating glaucoma
Inventor: LYNCH MARY G
IPC: A61F2/00
Filed: 2000-04-26
Abstract: Surgical catheter devices and methods for decompressing elevated intraocular pressure in eyes affected by glaucoma by performing a selected trabeculotomy from within Schlemm's canal.
Patent NZ-519492-A (NZ)
Title: A process for isolation of osteopontin from milk
Inventor: SORENSEN ESBEN SKIPPER
IPC: C07K1/30
Filed: 2001-01-04
Abstract: A  process  for  isolation of osteopontin  from  milk, wherein  a  milk  material  containing  osteopontin  with  a calcium  concentration of 0.05 -0.2% is pH adjusted to  keep osteopontin  in  solution  while  precipitating  other  milk constituents.
Patent NZ-519701-A (NZ)
Title: Thiazolyl amide derivatives
Inventor: FISCHER RUDIGER
IPC: C07F7/18
Filed: 2000-12-12
Abstract: Described are thiazolyl amide compounds of formula (I), for which the substituents are described herein. The compounds are used in the manufacture of medicaments for the treatment of viral infections, in particular herpes virus infections.
Patent NZ-520244-A (NZ)
Title: 4-aminopicolinates and their derivatives can be used as herbicides
Inventor: FIELDS STEPHEN CRAIG
IPC: C07D213/81
Filed: 2001-01-12
Abstract: 4-Aminopicolinic acids, having halogen, alkoxy, alkylthio, aryloxy, heteroaryloxy or trifluoromethyl substituents in the 3-, 5- and 6-positions, and their amine and agriculturally acceptable derivatives of the carboxylic acid of formula (I) that are potent herbicides demonstrating a broad spectrum of weed control are disclosed, wherein: X represents H, halogen, C1-C6 alkoxy, C1-C6 alkylthio, aryloxy, nitro, or trifluoromethyl; Y represents halogen, C1-C6 alkoxy, C1-C6 alkylthio, aryloxy, heteroaryloxy or trifluoromethyl; Z represents halogen, C1-C6 alkoxy, C1-C6 alkylthio, aryloxy or nitro; and W represents -NO2, -N3, -NR1R2, -N=CR3R4 or -NHN=CR3R4; wherein R1 and R2 independently represent H, C1-C6 alkyl, C3-C6 alkenyl, C3-C6 alkynyl, aryl, heteroaryl, hydroxy, C1-C6 alkoxy, amino, C1-C6 acyl, C1-C6 carboalkoxy, C1-C6 alkylcarbamyl, C1-C6 alkylsulfonyl, C1-C6 trialkylsilyl or C1-C6 dialkyl phosphonyl or R1 and R2 taken together with N represent a 5- or 6-membered saturated or unsaturated ring which may contain additional O, S or N heteroatoms ; and R3 and R4 independently represent H, C1-C6 alkyl, C3-C6 alkenyl, C3-C6 alkynyl, aryl or heteroaryl or R3 & R4 taken together with =C represent a 5- or 6-membered saturated ring ; with the proviso that when X represents H or Cl, then Y and Z are not both Cl, or when X and Z both represent Cl, then Y is not Br.
Patent NZ-520381-A (NZ)
Title: Production of pitch-based carbon foam and composites and uses thereof
Inventor: KLETT JAMES W
IPC: F28D20/02
Filed: 2001-03-05
Abstract: A thermally conductive carbon foam, normally having a thermal conductivity of at least 125 W/m. degree K is disclosed. The carbon foam usually has a specific thermal conductivity, defined as the thermal conductivity divided by the density, of at least about 175 W.cm3/m. degree K.gm. The foam also has a high specific surface area, typically at least about 6,000 m2/m3. The foam is characterized by an x-ray diffraction pattern having "doublet" 100 and 101 peaks characterized by a relative peak split factor no greater than about 0.470. The foam is graphitic and exhibits substantially isotropic thermal conductivity. The foam comprises substantially ellipsoidal pores and the mean pore diameter of such pores is preferably no greater than about 340 microns. Other materials, such as phase change materials, can be impregnated in the pores in order to impart beneficial thermal properties to the foam. Heat exchange devices and evaporatively cooled heat sinks utilizing the foams are also disclosed.
Patent NZ-526340-A (NZ)
Title: Wood tracheid length determination by light intensity attenuation or scatter pattern
Inventor: ANDREWS MICHAEL KENNETH
IPC: G01N21/898
Filed: 2002-06-11
Abstract: A method of obtaining a measure of fiber length of a wood specimen including the steps of , shining a light beam on at least one point of the surface of the specimen to create a light scatter pattern on a portion of the surface. Obtaining at least one measure of light intensity attenuation of the scatter pattern in at least one direction with respect to distance at least along one direction and determining a measure of fibre length from the measure of light attenuation. (62) Divided out of 519475
Patent NZ-528531-A (NZ)
Title: Colour image processing method and apparatus thereof
Inventor: CHOI YANG-LIM
IPC: G06V10/56
Filed: 2000-02-03
Abstract: A colour image processing method for retrieving a colour feature descriptor for describing colour features of an image, the method comprises: (a) Segmenting an input image into a plurality of regions; (b) Obtaining colour vectors of each of the plurality of regions; (c) Obtaining at least one class of the colour vectors by classifying the colour vectors of each of the plurality of regions based on a distribution of values of the colour vectors; (d) Obtaining at least one dominant colour and ration thereof, from the at least one class; and (e) Determining the at least one dominant colour and the ratio thereof as a colour feature descriptor of the input image. (62) Divided out of 513143
Patent NZ-535558-A (NZ)
Title: In situ recovery from a hydrocarbon containing formation
IPC: C09K8/592
Filed: 2001-04-24
Abstract: Disclosed is a method of treating a hydrocarbon containing formation in situ, comprising: Providing heat from at least two heat sources to at least a portion of the formation; Allowing the heat to transfer from the at least two heat sources to a selected section of the formation, wherein the selected section is heated in a reducing environment during at least a portion of the time that the selected section is being heated; and Producing a mixture from the formation; Wherein the formation conditions to produce the mixture are controlled to provide a partial pressure of H2, within the mixture of greater than about 0.5 bar; and Wherein superposition of heat from the at least two heat sources pyrolyzes at least some hydrocarbons within the selected section of the formation. (62) Divided Out of 522139
Patent NZ-538947-A (NZ)
Title: Solid oxide fuel cell stack assembly having tapered diffusion layers
Inventor: MILLIKEN CHRISTOPHER E
IPC: H01M8/24
Filed: 2003-09-26
Abstract: An electrochemical system is adapted to operate in a fuel cell mode, an electrolysis mode and a mode alternating between an electrolysis mode and a fuel cell mode, also referred to as an energy storage mode. The system operates on a fuel gas mixture entering the system via manifold 220 and an oxygen-containing gas mixture entering the system via manifold 222, and has tapered fuel diffusion layers 204 and oxygen diffusion layers 214, separated by respective fuel electrode 206, electrolyte disc 210, oxygen electrode 212, and electronically conductive impervious planar separators 216a, 216b separating each cell from an adjacent cell within the cell stack and electrically connecting each cell to an adjacent cell. The separators are in contact with the tapered side of the tapered fuel diffusion layer and the tapered side of the oxygen diffusion layer.
Patent NZ-539046-A (NZ)
Title: Chemotherapeutic self-emulsifying microemulsion compositions of paclitaxel with improved oral bioavailability
Inventor: GAO PING
IPC: A61K31/365
Filed: 2002-01-14
Abstract: Pharmaceutical compositions suitable for oral administration comprising paclitaxel, a solvent, a surfactant, a substituted cellulosic polymer, and optionally but preferably a P-glycoprotein inhibitor are disclosed. The composition may further comprise a diglyceride or mixture of diglyceride and monoglyceride. The composition generates a supersaturated paclitaxel microemulsion upon contact with water resulting in improved oral bioavailability of paclitaxel. Particularly disclosed is a composition for administering paclitaxel, wherein the composition is self-emulsifying; the composition comprising: (a) paclitaxel or an analog thereof; (b) a pharmaceutically acceptable surfactant; (c) a pharmaceutically acceptable solvent; and (d) a substituted cellulosic polymer; the paclitaxel and surfactant are present in a ratio of about 1.3 to 1:20 by weight; and the substituted cellulosic polymer and paclitaxel are present in a ratio of from about 50:1 to about 0.1:1 by weight. (62) Divided Out of 526977
Patent NZ-539165-A (NZ)
Title: Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
Inventor: GUZI TIMOTHY J
IPC: C07D487/04
Filed: 2003-09-03
Abstract: Disclosed are pyrazolo[1,5-a]pyrimidines of formula I wherein the substituents are as defined in the specification. Compounds of the type disclosed are protein kinase inhibitors (for example MAPK/ERK and GSK3beta) useful in the treatment of diseases such as cancer, inflammation, arthritis, viral disease, neurodegenerative diseases, cardiovascular diseases and fungal diseases.
Patent NZ-542912-A (NZ)
Title: Human serum albumin-free stabilized interferon liquid formulation comprising a buffer, a surfactant, an isotonicity agent, and an anti-oxidant wherein said anti-oxidant is methionine
Inventor: SAMARITANI FABRIZIO
IPC: A61K47/12
Filed: 2004-04-29
Abstract: Disclosed is a stabilized HSA-free liquid pharmaceutical composition comprising an interferon-beta (IFN-beta) wherein the composition is in a solution that comprises a buffer, a surfactant, an isotonicity agent and an antioxidant, and wherein said anti-oxidant is methionine. Further to this, the IFN-beta is human recombinant IFN-beta and the pH is between about 3 and about 5.
Patent NZ-547319-A (NZ)
Title: use of CRTH2 antagonist compounds in therapy
Inventor: MIDDLEMISS DAVID
IPC: C07D417/06
Filed: 2004-10-19
Abstract: Disclosed are 5-halo-indol-1-yl acetic acid derivatives of formulae I and II, wherein the substituents are as defined in the specification. The compounds useful for the treatment or prevention of diseases and conditions mediated by PGD2 at the CRTH2 receptor, such as allergic asthma, perennial allergic rhinitis, seasonal allergic rhinitis, atopic dermatitis, contact hypersensitivity (including contact dermatitis), conjunctivitis, especially allergic conjunctivitis, eosinophilic bronchitis, food allergies, eosinophilic gastroenteritis, inflammatory bowel disease, ulcerative colitis and Crohn's disease, mastocytosis, autoimmune diseases such as hyper IgE syndrome and systemic lupus erythematus, psoriasis, acne, multiple sclerosis, allograft rejection, reperfusion injury, chronic obstructive pulmonary disease, rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
Patent NZ-556427-A (NZ)
Title: method and apparatus for localized control of heat flux in thin cast strip
Inventor: SCHLICHTING MARK
IPC: B22D11/06
Filed: 2005-12-13
Abstract: A method of and apparatus for localized control of heat flux in continuous casting of thin cast strip comprising removing oxides from the casting surface of each casting roll by contacting the casting surface of each casting roll with the rotating brush in advance of the casting area, and delivering gas at the casting surface between the rotating brush and entry to the casting area to form a gas layer on the casting surface of each casting roll where the oxides have been removed. The delivering of gas at the casting surface between the rotating brush and entry to the casting area is preferably done in at least three zones along the casting roll axes to form a gas layer on the casting surface of each casting roll where the oxides have been removed, where the gas projected in the respective zones can be of different composition, mixture, pressure, or combination thereof.
Patent NZ-563869-A (NZ)
Title: Aerated food products and methods for producing them
Inventor: BURMESTER SABINA SILVIA HAENEL
IPC: A23L29/10
Filed: 2007-11-29
Abstract: Disclosed is an aerated food product comprising hydrophobin and a surfactant, the aerated food product containing a population of gas bubbles, wherein at least 65% of the gas bubbles have a diameter of less than 20ìm, with the proviso that the food product does not contain an ice structuring protein. Also disclosed is a method for making said aerated food product.
Patent NZ-564210-A (NZ)
Title: Blocks of wood agglomerate made in a mould that keeps the agglomerate under pressure untill cured
Inventor: VOGEL STEPHANE
IPC: B28B1/52
Filed: 2006-05-11
Abstract: A compressed block of wood agglomerate cured under pressure is disclosed. The block consists of wood particles and a hydraulic binder, produced by a method in which an initial mixture comprising wood particles and a hydraulic binder is held under pressure for the duration of the hardening of the binder. The particles of wood represent at least 75%, preferably from 75% to 95%, of the total volume of dry matter of the initial mixture and wherein the pressure is lower than 1MPa.The invention further relates to a method for production of said blocks and the use thereof in particular, as construction elements for buildings.
Patent NZ-568705-A (NZ)
Title: Methods for promoting neurite outgrowth and survival of dopaminergic neurons
Inventor: MI SHA
IPC: A61K39/00
Filed: 2006-11-03
Abstract: Disclosed is an in vitro method for promoting regeneration, outgrowth or survival of dopaminergic neurons, said method comprising contacting said dopaminergic neurons with a composition comprising an Sp35 antagonist selected from the group consisting of: (i) a soluble Sp35 polypeptide; (ii) an Sp35 antibody or immunospecific fragment thereof; (iii) an Sp35 antagonist polynucleotide, (iv) an Sp35 aptamer; and (v) a combination of two or more of said Sp35 antagonists, wherein said Sp35 antagonist is capable of inhibiting the binding of Sp35 to EGFR. Also disclosed is of an Sp35 antibody or immunospecific fragment thereof that is capable of inhibiting the binding of Sp35 to EGFR in the preparation of a medicament for treating a disease, disorder or injury in a mammal, wherein the disease, disorder, or injury is selected from the group consisting of Parkinson's disease, multiple system atrophy, striatonigral degeneration, olivopontocerebellar atrophy, Shy-Drager syndrome, motor neuron disease with parkinsonian features, Lewy body dementia, progressive supranuclear palsy, cortical-basal ganglionic degeneration, frontotemporal dementia, Wilson disease, Hallervordern-Spatz disease, Chediak-Hagashi disease, SCA-3 spinocerebellar ataxia, X-linked dystoniaparkinsonism (DYT3), Huntington's disease (Westphal variant), prion disease, Jacob- Creutzfeldt disease (CJD), vascular parkinsonism, cerebral palsy, repeated head trauma, postencephalitic parkinsonism, neurosyphilis, and schizophrenia.
Patent NZ-571099-A (NZ)
Title: Hot dip galvannealed steel material having an zinc alloy plated layer containing at least 12% magnesium
Inventor: NOSE KOICHI
IPC: C22C23/04
Filed: 2007-03-14
Abstract: Disclosed is a high corrosion resistance hot dip galvanised steel material having an alloy plated layer containing zinc in an amount of 35 mass % or more and magnesium in an amount of 12 to 60 mass % and Al in an amount of 0.07 to 45%, wherein said alloy plated layer contains a non-equilibrium phase with a heat capacity by differential scanning calorimetry of 1 J/g or more.
Patent NZ-571460-A (NZ)
Title: Methods of treating hot flashes with formulations for transdermal or transmucosal application
Inventor: SIMES STEPHEN M
IPC: A61K9/06
Filed: 2007-04-04
Abstract: Disclosed is a topical transdermal or transmucosal formulation comprising: Estrogen in an amount of between about 0.01% to 10% by weight of the formulation; and a delivery vehicle comprising a C2 to C4 alkanol, a polyalcohol, and a permeation enhancer of monoalkyl ether of diethylene glycol present in an amount sufficient to provide permeation enhancement of the active agent through dermal or mucosal surfaces; wherein the formulation provides a daily dosage of between about 0.45 mg to about 0.6 mg of estrogen when applied in an amount of about 0.75 g to about 1 g per day. Also disclosed a method of preparing the said topical transdermal or transmucosal formulation. Also disclosed is the use of the said formulation for the preparation of a medicament for the treatment of hot flashes.
Patent NZ-574581-A (NZ)
Title: Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
Inventor: VAN DEN BRINK EDWARD NORBERT
IPC: C07K16/10
Filed: 2007-09-06
Abstract: An isolated human binding molecule capable of recognizing and binding to an epitope in the HA2 subunit of the influenza haemagglutinin protein (HA), characterized in that said binding molecule has neutralizing activity against an influenza virus comprising HA of the H5 subtype, such as H5N1, H5N2, H5N8, and H5N9, and in that said binding molecule comprises the VH germline VH1-69.
Patent NZ-583042-A (NZ)
Title: Bearing members for load bearing comprising two bearing elements that are slidabe to each other
Inventor: ALLINGTON CHRISTOPHER JAMES
IPC: F16C29/00
Filed: 2010-02-02
Abstract: 583042 Disclosed is a bearing member for incorporation in a first structural member. The first structural member is slidably connected in use to a load-bearing contact with a second structural member along a structural member interface between the first and second structural members. The bearing member includes first and second bearing layers which each have a sliding surface and an opposing contact surface orientated in use to face the respective first or second structural member. When connected the first and second bearing layer sliding surfaces directly abut each other sharing a mutual sliding interface such that under relative sliding movement of the first and second structural members the first and second bearing layers are capable of sliding relative to each other about the abutting sliding surfaces.
Patent NZ-585734-A (NZ)
Title: Utilization of acetic acid reaction heat in other process plants
Inventor: BHASKARAN SUBRAMANIAN
IPC: C07C67/05
Filed: 2005-02-24
Abstract: Disclosed is an integrated process for the production of acetic acid and vinyl acetate comprising the steps of: (a) producing in a first reaction zone a first product stream comprising acetic acid wherein the acetic acid is produced using an exothermic carbonylation reaction, and wherein at least a portion of the heat from the production of acetic acid is removed from the first reaction zone and at least a portion of the heat removed from the production of acetic acid is transferred in a heat transfer system, wherein the heat transfer system comprises a steam condensate loop in which the heat from the production of the acetic acid is removed from the first reaction zone through heat exchange between a hot reactor solution stream and a steam condensate stream; (b) contacting in a second reaction zone an acetic acid reaction stream comprised of at least a portion of the acetic acid from the first product stream with an oxygen-containing gas in the presence of a catalyst to produce a second product stream comprising vinyl acetate monomer; (c) directing at least a portion of the second product stream to a purification section to purify the vinyl acetate in the second product stream; and (d) wherein at least a portion of the heat transferred to the steam condensate loop is provided to the second reaction zone of step (b) or is provided to the purification zone of step (c).
Patent NZ-591022-A (NZ)
Title: An asynchronous power generator for a wind turbine
Inventor: EGEDAL PER
IPC: H02P9/00
Filed: 2009-08-19
Abstract: 591022 Disclosed is an asynchronous power generator for a wind turbine and a method of voltage control for reducing noise from an asynchronous power generator. The asynchronous power generator comprises a voltage supply (20) and a stator (12) with at least one stator coil (16, 16', 16", 16'") supplied with an alternating voltage by the voltage supply (20). The voltage supply (20) is configured to adjust the voltage supplied to the stator coil (16, 16', 16", 16'") based on the output power generated by the wind turbine for reducing nose from the asynchronous power generator. The voltage supplied to the at least one stator coil (16, 16', 16", 16'") is adjusted such that the normalised flux occurring in the at least one stator coil (16, 16', 16", 16'") depends on the output power as: ? = ?.P + ?.Ratio; wherein P is the output power, a is a slope and P.Ratio is a y-intercept. The y-intercept is scaled to a value such that the optimal power output of the wind turbine at a given speed is less than a maximum power output that can be achieved at that speed for that value of the y-intercept.
Patent NZ-594236-A (NZ)
Title: Use of pterosin compounds for treating diabetes and obesity
Inventor: UANG BIING-JUAN
IPC: A61K31/12
Filed: 2010-01-26
Abstract: Disclosed is the use of specific pterosin compounds of formula (I) in the manufacture of a medicament for treating diabetes or obesity in a subject, wherein the substituents are as defined herein. Compounds of formula (I) include compounds such as (S)-6-(2-hydroxy-ethyl)-2-hydroxymethyl-2,5,7-trimethyl-indan-1-one, (2S,3S)-6-(2-hydroxy-ethyl)-3-hydroxy-2,5,7-trimethyl-indan-1-one, 6-(2-chloro-ethyl)-2,2,5,7-tetramethyl-indan-1-one and (2R,3R)-6-(2-hydroxy-ethyl)-2-hydroxymethyl-3-hydroxy-2,5,7-trimethyl-indan-1-one.
Patent NZ-594412-A (NZ)
Title: 5-beta, 14-beta-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure
Inventor: FERRARI PATRIZIA
IPC: A61K31/58
Filed: 2010-03-18
Abstract: Disclosed herein is the use of 17-?-(3-furyl) and (4-pyridazinyl)-5-?, 14-?-androstane compounds of formula (I), for the manufacture of a medicament useful in the treatment of proteinuria, glomerulosclerosis and renal failure, wherein the substituents are as defined within the specification. Examples of particularly preferred compounds include: 17-?-(3-furyl)-5-?-androstane-3-?, 14-?, 17-?-triol; 3-?-(2-hydroxyethoxy)-17-?-(3-furyl)-5-?-androstane-14-?, 17-?-diol; 3-?-(2-aminoethoxy)-17-?-(3-furyl)-5-?-androstane-14-?, 17-?-diol; 3-?-(3-aminopropoxy)-17-?-(3-furyl)-5-?-androstane-14-?, 17-? -diol; 3-?-(2-methylaminoethoxy)-17-?-(3-furyl)-5-?-androstane-14-?, 17-?-diol; 3-?-(2-(1-pyrrolidinyl)ethoxy)-17-?-(3-furyl)-5-?-androstane-14-?, 17-?-diol; 3-?-(3-(1-pyrrolidinyl)propoxy)-17-?-(3-furyl)-5-?-androstane-14-?, 17-?-diol; 3-?-(2-(1-imidazolyl)ethoxy)-17-?-(3-furyl)-5-?-androstane-14-?, 17-?-diol; 3-?-(2-(2-imidazolin-2-yl)ethoxy)-17-?-(3-furyl)-5-?-androstane-14-?, 17-?-diol.
Patent NZ-596872-A (NZ)
Title: Improved method for synthesizing pirfenidone
Inventor: CYR MIKE
IPC: A61K31/4412
Filed: 2010-06-02
Abstract: 596872 Provided is a process for synthesising pirfenidone using bromobenzene comprising less than 0.15% by weight dibromobenzene, and copper (I) oxide as a catalyst. Further provided are processes for synthesising pirfenidone without using ethyl acetate or n-butanol, and for producing pirfenidone having controlled levels of ethyl acetate, n-butanol, di(5-methyl-2-pyridinone)benzenes, and other impurities. Also provided is a pharmaceutical composition comprising pirfenidone synthesised by the process and processes wherein the pirfenidone synthesised is formulated into dosage forms such as tablets.